Drug: REMODULIN Injury: Headache Quarter: 2016Q3
Total Records: 156 Number of Pages: 8
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
103940606 | REMODULIN | Headache | ACTELION | 56.00 YR | M | 44 KG | 20160804 | US |
105545596 | REMODULIN | Headache | GLAXOSMITHKLINE | 11.82 YR | M | 0 | 20160822 | US |
113188812 | REMODULIN | Headache | ACTELION | 27.00 YR | F | 0 | 20160912 | US |
113189076 | REMODULIN | Headache | ACTELION | 46.00 YR | F | 0 | 20160906 | US |
114008095 | REMODULIN | Headache | ACTELION | 28.00 YR | F | 0 | 20160804 | US |
119138416 | REMODULIN | Headache | GILEAD | 43.00 YR | F | 0 | 20160706 | US |
119428302 | REMODULIN | Headache | UNITED THERAPEUTICS | 83.74 YR | F | 95 KG | 20160726 | US |
119434702 | REMODULIN | Headache | UNITED THERAPEUTICS | 46.48 YR | F | 110 KG | 20160726 | US |
119440312 | REMODULIN | Headache | UNITED THERAPEUTICS | 71.00 YR | F | 60 KG | 20160726 | US |
119442563 | REMODULIN | Headache | UNITED THERAPEUTICS | 70.23 YR | M | 68 KG | 20160726 | US |
120369804 | REMODULIN | Headache | BRISTOL MYERS SQUIBB | 43.00 YR | F | 0 | 20160724 | US |
121470499 | REMODULIN | Headache | ACTELION | 39.00 YR | F | 0 | 20160930 | US |
121591094 | REMODULIN | Headache | UNITED THERAPEUTICS | 77.34 YR | F | 62 KG | 20160726 | US |
122308618 | REMODULIN | Headache | UNITED THERAPEUTICS | 54.99 YR | F | 51 KG | 20160826 | US |
123418928 | REMODULIN | Headache | ACTELION | 63.00 YR | F | 0 | 20160908 | US |
123427925 | REMODULIN | Headache | BAYER | 47.00 YR | F | 72 KG | 20160727 | US |
123511492 | REMODULIN | Headache | BAYER | 54.00 YR | F | 0 | 20160914 | US |
123601373 | REMODULIN | Headache | ACTELION | 54.00 YR | F | 0 | 20160926 | US |
123727974 | REMODULIN | Headache | UNITED THERAPEUTICS | 70.32 YR | M | 66 KG | 20160728 | US |
124126006 | REMODULIN | Headache | UNITED THERAPEUTICS | 16.75 YR | M | 120 KG | 20160809 | US |
Total Records: 156 Number of Pages: 8